*Victor Gorgievski¹, El Cherif Ibrahim³, Marguerite Le Marois³, Raoul Belzeaux⁴, Eleni Tzavara² (1. Université Paris Cité T3S INSERM, 2. CNRS UMR8002 Université Paris Cité, 3. Aix Marseille Université INT CNRS, 4. CHU Montpellier)

*Ryo Fukumori¹, Ryosuke Nakajima¹, Kanan Ueo¹, Taku Yamaguchi¹ (1. Nagasaki International University)

*Gavin Afonso¹, Shannon Waye, Tadhg M. Strand, Francis Bambico (1. Department of Psychology, Memorial University of Newfoundland and Labrador, St. John's, Newfoundland and Labrador, Canada)

*Cheng-Ta Li¹, Chih-Ming Cheng¹, Hui-Ting Wu³, Ya-Mei Bai¹, Tung-Ping Su² (1. Department of Psychiatry, Taipei Veterans General Hospital, Taiwan, 2. School of Medicine, National Yang Ming Chiao Tung University, Taiwan, 3. Institute of Brain Science, National Yang Ming Chiao Tung University, Taiwan)

*Jenessa Johnston¹, Brandi Quintanilla^1,2, Peixiong Yuan¹, Shiyong Peng¹, Mani Yavi¹, Hector Caruncho³, Bashkim Kadriu^1,4, Carlos Zarate Jr. ¹ (1. National Institute of Mental Health, 2. UT Health Houston, 3. University of Victoria, 4. Jazz Pharmaceuticals)

*Daisuke Ibi¹, Rika Takaba¹, Keisuke Yoshida², Takayoshi Mamiya¹, Shinji Kitagaki², Masayuki Hiramatsu¹ (1. Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, 2. Department of Medical Chemistry, Faculty of Pharmacy, Meijo University)

*Chemin Lin¹, Shwu-Hua Lee², Chih-Mao Huang³, Yu-Wen Wu⁴, You-Xun Chang⁴, Ho-Ling Liu⁵, Shu-Hang Ng⁶, Ying-Chih Cheng⁷, Chih-Chiang Chiu⁸, Shun-Chi Wu Wu⁴ (1. Department of Psychiatry, Keelung Chang Gung Memorial Hospital, Keelung City, Taiwan, 2. Department of Psychiatry, Linkou Chang Gung Memorial Hospital, Taoyuan County, Taiwan, 3. Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, Taiwa, 4. Department of Engineering and System Science, National Tsing Hua University, Hsinchu, Taiwan, 5. Department of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, Texas, 6. Department of Diagnostic Radiology, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, 7. Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan, 8. Department of Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan )

*Shuhei Ueda^1,2, Masahito Hosokawa^3,4,5, Manami Kakita¹, Koji Arikawa⁴, Hiroko Matsunaga⁴, Haruko Takeyama^3,4,5, Sayaka Takemoto-Kimura^1,2 (1. Department of Neuroscience I, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan, 2. Molecular/Cellular Neuroscience, Nagoya University Graduate School of Medicine, Nagoya University, Nagoya, Japan, 3. Department of Life Science and Medical Bioscience, Waseda University, Tokyo, Japan, 4. Research Organization for Nano and Life Innovation, Waseda University, Tokyo, Japan, 5. Institute for Advanced Research of Biosystem Dynamics, Waseda Research Institute for Science and Engineering)

*Hideo Hagihara¹, Tsuyoshi Miyakawa¹ (1. Division of Systems Medical Science, Center for Medical Science, Fujita Health University, Toyoake, Japan)

*Samar Salah Mohamedahmed Elsheikh¹, Victoria Marshe², James Kennedy^1,3, Guillaume Paré⁴, Corinne Fischer⁵, Daniel Felsky^1,3, Daniel Mueller^1,3 (1. Center for Addiction and Mental Health, Toronto, ON, Canada, 2. Colombia University, New York, NY, USA, 3. University of Toronto, Toronto, ON, Canada, 4. McMaster University, Hamilton, ON, Canada, 5. St. Michael's Hospital, Toronto, ON, Canada)

*Xiaoyu Men^1,2, Zachary L. Taylor^3,4, Victoria S. Marshe⁵, Daniel M. Blumberger^2,6, Jordan F. Karp⁷, James L. Kennedy^2,6, Eric J. Lenze⁸, Charles F. Reynolds III⁹, Cristiana Stefan^2,10, Benoit H. Mulsant^2,6, Laura B. Ramsey^3,4,11, Daniel J. Müller^1,2,6 (1. Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada , 2. Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada, 3. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA, 4. Division of Clinical Pharmacology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA, 5. Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA, 6. Department of Psychiatry, University of Toronto, Toronto, ON, Canada, 7. Department of Psychiatry, The University of Arizona College of Medicine, Tucson, AZ, USA, 8. Department of Psychiatry, Washington University, St. Louis, MO, USA, 9. Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA, 10. Clinical Laboratory and Diagnostic Services, Centre for Addiction and Mental Health, Toronto, ON, Canada, 11. Division of Research in Patient Services, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA)

*Mizuki Yamamoto¹, Kazuko Hayashi¹, Masashi Kanayama², Kyoko Tagashira¹, Shuntaro Matsushima¹, Haruki kasahara¹, Hiroto Inoue¹, Koji Toda¹ (1. Keio University, 2. Tokyo Medical and Dental University)